פונגימון
trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".
אמוקסי קאר פורטה 250 תרחיף
vitamed pharmaceutical industries ltd - amoxicillin as trihydrate - אבקה להכנת תרחיף - amoxicillin as trihydrate 250 mg / 5 ml - amoxicillin
מוקולס תמיסה
vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2 mg/ml - bromhexine
סולפמתופרים וטרינרי
abic veterinary products ltd - sulfadiazine sodium; trimethoprim - תמיסה (פומי) - trimethoprim 16 mg/ml; sulfadiazine sodium 86.4 mg/ml
אגיספור ג'ל
padagis israel pharmaceuticals ltd, israel - bifonazole - ג'ל - bifonazole 1 %w/w - bifonazole - bifonazole - broad spectrum antimycotic agent.
אגיספור קרם
perrigo israel pharmaceuticals ltd - bifonazole 1 % - cream - bifonazole - broad spectrum antimycotic agent.
אגיספור תמיסה
padagis israel pharmaceuticals ltd, israel - bifonazole - תמיסה - bifonazole 1 %w/v / 100 ml - bifonazole - bifonazole - broad spectrum antimycotic agent.
אגיסטן וי % 2 קרם וגינלי
padagis israel pharmaceuticals ltd, israel - clotrimazole - קרם וגינלי - clotrimazole 2 % - clotrimazole - clotrimazole - broad spectrum antimycotic with fungicidal action
ציפרודקס 250
dexcel ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 250 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.
ציפרודקס 500
dexcel ltd, israel - ciprofloxacin as hydrochloride - קפליות - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.